HEADER APOPTOSIS/INHIBITOR 26-OCT-17 6BFL TITLE CASPASE-3 MUTANT- D9A,D28A,T245D CAVEAT 6BFL THE DISTANCE BETWEEN THE S OF CYS 163 AND THE C-TERMINUS OF CAVEAT 2 6BFL THE INHIBITOR IS TOO LONG FOR COVALENT BOND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CASP-3,APOPAIN,CYSTEINE PROTEASE CPP32,CPP-32,PROTEIN YAMA, COMPND 5 SREBP CLEAVAGE ACTIVITY 1,SCA-1; COMPND 6 EC: 3.4.22.56; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-3; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: CASP-3,APOPAIN,CYSTEINE PROTEASE CPP32,CPP-32,PROTEIN YAMA, COMPND 13 SREBP CLEAVAGE ACTIVITY 1,SCA-1; COMPND 14 EC: 3.4.22.56; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: AC-ASP-GLU-VAL-ASP-CMK; COMPND 19 CHAIN: C; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CASP3, CPP32; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_TAXID: 9606 KEYWDS ALLOSTERIC REGULATION; APOPTOSIS; BIOPHYSICS; CASPASE; COMPUTATIONAL KEYWDS 2 BIOLOGY; X-RAY CRYSTALLOGRAPHY; FLUORESCENCE; MOLECULAR DYNAMICS; KEYWDS 3 PROTEIN EVOLUTION, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.E.THOMAS,R.GRINSHPON,P.D.SWARTZ,A.C.CLARK REVDAT 2 25-APR-18 6BFL 1 JRNL REVDAT 1 21-FEB-18 6BFL 0 JRNL AUTH M.E.THOMAS,R.GRINSHPON,P.SWARTZ,A.C.CLARK JRNL TITL MODIFICATIONS TO A COMMON PHOSPHORYLATION NETWORK PROVIDE JRNL TITL 2 INDIVIDUALIZED CONTROL IN CASPASES. JRNL REF J. BIOL. CHEM. V. 293 5447 2018 JRNL REFN ESSN 1083-351X JRNL PMID 29414778 JRNL DOI 10.1074/JBC.RA117.000728 REMARK 2 REMARK 2 RESOLUTION. 1.87 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 27242 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.157 REMARK 3 R VALUE (WORKING SET) : 0.154 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.330 REMARK 3 FREE R VALUE TEST SET COUNT : 1998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.6882 - 4.2736 1.00 1925 152 0.1511 0.1725 REMARK 3 2 4.2736 - 3.3929 1.00 1861 148 0.1367 0.1860 REMARK 3 3 3.3929 - 2.9643 1.00 1838 145 0.1569 0.1934 REMARK 3 4 2.9643 - 2.6933 1.00 1806 142 0.1648 0.2009 REMARK 3 5 2.6933 - 2.5003 1.00 1805 143 0.1587 0.1888 REMARK 3 6 2.5003 - 2.3530 1.00 1817 145 0.1536 0.1861 REMARK 3 7 2.3530 - 2.2351 1.00 1809 143 0.1487 0.1889 REMARK 3 8 2.2351 - 2.1379 1.00 1780 141 0.1453 0.1888 REMARK 3 9 2.1379 - 2.0556 1.00 1809 143 0.1568 0.1893 REMARK 3 10 2.0556 - 1.9846 1.00 1802 143 0.1559 0.1855 REMARK 3 11 1.9846 - 1.9226 1.00 1783 142 0.1675 0.2025 REMARK 3 12 1.9226 - 1.8676 1.00 1791 140 0.1638 0.2283 REMARK 3 13 1.8700 - 1.8185 1.00 1765 140 0.1798 0.1850 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2166 REMARK 3 ANGLE : 1.078 2926 REMARK 3 CHIRALITY : 0.051 309 REMARK 3 PLANARITY : 0.005 385 REMARK 3 DIHEDRAL : 12.672 818 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: AUTHORS INDICATE THAT IS NOT POSSIBLE REMARK 3 TO DEFINE THE COVALENT BOND BETWEEN THE CYSTEINE SULFUR ATOM AND REMARK 3 THE CARBON ATOM OF THE INHIBITOR IN PHENIX. REMARK 4 REMARK 4 6BFL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1000230823. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-AUG-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44845 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.870 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE OBTAINED AT 18 C BY THE REMARK 280 HANGING DROP VAPOR DIFFUSION METHOD USING 4 ML DROPS THAT REMARK 280 CONTAINED EQUAL VOLUMES OF PROTEIN AND RESERVOIR SOLUTIONS OVER REMARK 280 A 0.5 ML SOLUTION OF 100 MM SODIUM CITRATE, PH 4.9-5.2, 8-18 % REMARK 280 PEG 6000 (W/V), 10 MM DTT, AND 3 MM NAN3. CRYSTALS APPEARED REMARK 280 WITHIN 3-5 DAYS AND WERE BRIEFLY IMMERSED IN A CRYOGENIC REMARK 280 SOLUTION CONTAINING 10% MPD (2-METHYLPENTANE-2,4-DIOL) AND 90% REMARK 280 RESERVOIR SOLUTION., VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.15500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.39200 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.11000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.15500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.39200 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.11000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.15500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 42.39200 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 48.11000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.15500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 42.39200 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 48.11000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 502 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-CMK IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-CMK REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ASN A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 VAL A 8 REMARK 465 ALA A 9 REMARK 465 SER A 10 REMARK 465 LYS A 11 REMARK 465 SER A 12 REMARK 465 ILE A 13 REMARK 465 LYS A 14 REMARK 465 ASN A 15 REMARK 465 LEU A 16 REMARK 465 GLU A 17 REMARK 465 PRO A 18 REMARK 465 LYS A 19 REMARK 465 ILE A 20 REMARK 465 ILE A 21 REMARK 465 HIS A 22 REMARK 465 GLY A 23 REMARK 465 SER A 24 REMARK 465 GLU A 25 REMARK 465 SER A 26 REMARK 465 MET A 27 REMARK 465 ALA A 28 REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 ILE A 31 REMARK 465 SER A 32 REMARK 465 LEU A 33 REMARK 465 ASP A 175 REMARK 465 SER B 176 REMARK 465 GLY B 177 REMARK 465 VAL B 178 REMARK 465 ASP B 179 REMARK 465 ASP B 180 REMARK 465 ASP B 181 REMARK 465 MET B 182 REMARK 465 ALA B 183 REMARK 465 CYS B 184 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS B 185 CG ND1 CD2 CE1 NE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 173 CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 80 O HOH A 401 2.16 REMARK 500 O HOH A 401 O HOH A 429 2.18 REMARK 500 O HOH A 424 O HOH B 303 2.19 REMARK 500 O HOH A 497 O HOH A 512 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS B 229 -36.65 -136.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU C 3 -10.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AZI A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Ac-Asp-Glu-Val-Asp-CMK chain C DBREF 6BFL A 1 175 UNP P42574 CASP3_HUMAN 1 175 DBREF 6BFL B 176 277 UNP P42574 CASP3_HUMAN 176 277 DBREF 6BFL C 1 6 PDB 6BFL 6BFL 1 6 SEQADV 6BFL ALA A 9 UNP P42574 ASP 9 ENGINEERED MUTATION SEQADV 6BFL ALA A 28 UNP P42574 ASP 28 ENGINEERED MUTATION SEQADV 6BFL ASP B 245 UNP P42574 THR 245 ENGINEERED MUTATION SEQRES 1 A 175 MET GLU ASN THR GLU ASN SER VAL ALA SER LYS SER ILE SEQRES 2 A 175 LYS ASN LEU GLU PRO LYS ILE ILE HIS GLY SER GLU SER SEQRES 3 A 175 MET ALA SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 4 A 175 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 5 A 175 LYS ASN PHE HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 6 A 175 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 7 A 175 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 8 A 175 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 9 A 175 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 10 A 175 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 11 A 175 ASN GLY PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE SEQRES 12 A 175 ARG GLY ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS SEQRES 13 A 175 LEU PHE ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 14 A 175 CYS GLY ILE GLU THR ASP SEQRES 1 B 102 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 B 102 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 B 102 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 B 102 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 B 102 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 B 102 ARG LYS VAL ALA ASP GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 B 102 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 B 102 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS SEQRES 1 C 6 ACE ASP GLU VAL ASP 0QE HET ACE C 1 3 HET 0QE C 6 1 HET AZI A 301 3 HETNAM ACE ACETYL GROUP HETNAM 0QE CHLOROMETHANE HETNAM AZI AZIDE ION HETSYN 0QE CHLORO METHYL GROUP FORMUL 3 ACE C2 H4 O FORMUL 3 0QE C H3 CL FORMUL 4 AZI N3 1- FORMUL 5 HOH *212(H2 O) HELIX 1 AA1 HIS A 56 GLY A 60 5 5 HELIX 2 AA2 GLY A 66 LEU A 81 1 16 HELIX 3 AA3 THR A 92 LYS A 105 1 14 HELIX 4 AA4 LEU A 136 PHE A 142 1 7 HELIX 5 AA5 CYS A 148 THR A 152 5 5 HELIX 6 AA6 TRP B 214 ALA B 227 1 14 HELIX 7 AA7 GLU B 231 PHE B 247 1 17 HELIX 8 AA8 ASP B 253 HIS B 257 5 5 SHEET 1 AA1 6 GLU A 84 ASN A 89 0 SHEET 2 AA1 6 GLU A 43 ASN A 51 1 N ASN A 51 O LYS A 88 SHEET 3 AA1 6 ARG A 111 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 AA1 6 LYS A 156 GLN A 161 1 O LEU A 157 N PHE A 114 SHEET 5 AA1 6 PHE B 193 TYR B 197 1 O LEU B 194 N PHE A 158 SHEET 6 AA1 6 CYS B 264 SER B 267 -1 O VAL B 266 N TYR B 195 SHEET 1 AA2 3 GLY A 122 GLU A 123 0 SHEET 2 AA2 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 AA2 3 GLY A 132 ASP A 135 -1 O VAL A 134 N ILE A 127 SHEET 1 AA3 3 GLY B 212 SER B 213 0 SHEET 2 AA3 3 TRP B 206 ASN B 208 -1 N ASN B 208 O GLY B 212 SHEET 3 AA3 3 GLU C 3 VAL C 4 -1 O GLU C 3 N ARG B 207 LINK C ACE C 1 N ASP C 2 1555 1555 1.30 LINK C ASP C 5 C1 0QE C 6 1555 1555 1.54 SITE 1 AC1 5 GLY A 66 THR A 67 ASP A 68 VAL A 69 SITE 2 AC1 5 HOH A 408 SITE 1 AC2 23 SER A 58 ARG A 64 HIS A 121 GLY A 122 SITE 2 AC2 23 GLN A 161 CYS A 163 HOH A 415 HOH A 461 SITE 3 AC2 23 SER B 205 TRP B 206 ARG B 207 ASN B 208 SITE 4 AC2 23 SER B 209 TRP B 214 SER B 249 PHE B 250 SITE 5 AC2 23 HOH B 324 HOH C 101 HOH C 102 HOH C 103 SITE 6 AC2 23 HOH C 104 HOH C 105 HOH C 106 CRYST1 68.310 84.784 96.220 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014639 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011795 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010393 0.00000